Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

The ClockΔ19 mutation in mice fails to alter the primary and secondary reinforcing properties of nicotine.

Bernardi RE, Spanagel R.

Drug Alcohol Depend. 2013 Dec 1;133(2):733-9. doi: 10.1016/j.drugalcdep.2013.08.024. Epub 2013 Sep 5.

PMID:
24054990
2.

The necessity of α4* nicotinic receptors in nicotine-driven behaviors: dissociation between reinforcing and motor effects of nicotine.

Cahir E, Pillidge K, Drago J, Lawrence AJ.

Neuropsychopharmacology. 2011 Jun;36(7):1505-17. doi: 10.1038/npp.2011.35. Epub 2011 Mar 23.

3.

Effects of ultra-low doses of nicotine on the expression of morphine-induced conditioned place preference in mice.

Shams J, Sahraei H, Gholami A, Haeri-Rohani A, Alaf-Javadi M, Sepehri H, Salimi SH, Ghoshooni H.

Behav Pharmacol. 2006 Nov;17(7):629-35.

PMID:
17021396
4.

Cocaine self-administration behaviors in ClockΔ19 mice.

Ozburn AR, Larson EB, Self DW, McClung CA.

Psychopharmacology (Berl). 2012 Sep;223(2):169-77. doi: 10.1007/s00213-012-2704-2. Epub 2012 Apr 26.

5.

Basal activity level in mice predicts the initial and sensitized locomotor response to nicotine only in high responders.

Bernardi RE, Spanagel R.

Behav Brain Res. 2014 May 1;264:143-50. doi: 10.1016/j.bbr.2014.01.046. Epub 2014 Feb 5.

PMID:
24508239
6.

Operant responding for conditioned and unconditioned reinforcers in rats is differentially enhanced by the primary reinforcing and reinforcement-enhancing effects of nicotine.

Chaudhri N, Caggiula AR, Donny EC, Booth S, Gharib M, Craven L, Palmatier MI, Liu X, Sved AF.

Psychopharmacology (Berl). 2006 Nov;189(1):27-36. Epub 2006 Sep 22.

PMID:
17019569
7.

The neuropharmacological substrates of nicotine reward: reinforcing versus reinforcement-enhancing effects of nicotine.

Paterson NE.

Behav Pharmacol. 2009 May;20(3):211-25. doi: 10.1097/FBP.0b013e32832c7083. Review.

PMID:
19421028
8.

Conditioned reinforcement in rats established with self-administered nicotine and enhanced by noncontingent nicotine.

Palmatier MI, Liu X, Matteson GL, Donny EC, Caggiula AR, Sved AF.

Psychopharmacology (Berl). 2007 Dec;195(2):235-43. Epub 2007 Aug 5.

9.

Ascorbic acid antagonizes nicotine-induced place preference and behavioral sensitization in mice.

Sahraei H, Aliabadi AA, Zarrindast MR, Ghoshooni H, Nasiri A, Barzegari-Sorkheh AA, Yari M, Zardooz H, Hossein-Mardi L, Faraji N, Shams J.

Eur J Pharmacol. 2007 Mar 29;560(1):42-8. Epub 2007 Jan 19.

PMID:
17292882
10.

Activation of 5-HT(2C) receptors reduces the locomotor and rewarding effects of nicotine.

Grottick AJ, Corrigall WA, Higgins GA.

Psychopharmacology (Berl). 2001 Sep;157(3):292-8.

PMID:
11605085
11.

Effect of forced chronic oral nicotine exposure on intravenous self-administration and rewarding properties of acute nicotine.

Tammimäki A, Chistyakov V, Patkina N, Skippari J, Ahtee L, Zvartau E, Männistö PT.

Eur J Pharmacol. 2008 Sep 4;591(1-3):164-70. doi: 10.1016/j.ejphar.2008.06.081. Epub 2008 Jun 27.

PMID:
18606163
12.

Nicotine in alcohol deprivation increases alcohol operant self-administration during reinstatement.

López-Moreno JA, Trigo-Díaz JM, Rodríguez de Fonseca F, González Cuevas G, Gómez de Heras R, Crespo Galán I, Navarro M.

Neuropharmacology. 2004 Dec;47(7):1036-44.

PMID:
15555637
13.

Lack of CB1 cannabinoid receptors modifies nicotine behavioural responses, but not nicotine abstinence.

Castañé A, Valjent E, Ledent C, Parmentier M, Maldonado R, Valverde O.

Neuropharmacology. 2002 Oct;43(5):857-67.

PMID:
12384171
14.

Assessment of nicotinic acetylcholine receptor subunit contributions to nicotine self-administration in mutant mice.

Epping-Jordan MP, Picciotto MR, Changeux JP, Pich EM.

Psychopharmacology (Berl). 1999 Nov;147(1):25-6. No abstract available.

PMID:
10591862
15.

Differential effects of 5-HT2C receptor activation by WAY 161503 on nicotine-induced place conditioning and locomotor activity in rats.

Hayes DJ, Mosher TM, Greenshaw AJ.

Behav Brain Res. 2009 Feb 11;197(2):323-30. doi: 10.1016/j.bbr.2008.08.034. Epub 2008 Sep 2.

PMID:
18805442
16.

Nicotine-induced conditioned place preference and conditioned place aversion in mice.

Risinger FO, Oakes RA.

Pharmacol Biochem Behav. 1995 Jun-Jul;51(2-3):457-61.

PMID:
7667368
17.

The effects of nitric oxide on the acquisition and expression of nicotine-induced conditioned place preference in mice.

Sahraei H, Falahi M, Zarrindast MR, Sabetkasaei M, Ghoshooni H, Khalili M.

Eur J Pharmacol. 2004 Oct 25;503(1-3):81-7.

PMID:
15496300
18.

Attenuation of nicotine-induced rewarding effects in A2A knockout mice.

Castañé A, Soria G, Ledent C, Maldonado R, Valverde O.

Neuropharmacology. 2006 Sep;51(3):631-40. Epub 2006 Jun 21.

PMID:
16793068
19.

Isradipine inhibits nicotine intravenous self-administration in drug-naive mice.

Martellotta MC, Kuzmin A, Zvartau E, Cossu G, Gessa GL, Fratta W.

Pharmacol Biochem Behav. 1995 Oct;52(2):271-4.

PMID:
8577790
20.

Intravenous nicotine conditions a place preference in rats using an unbiased design.

Wilkinson JL, Bevins RA.

Pharmacol Biochem Behav. 2008 Jan;88(3):256-64. Epub 2007 Sep 1.

Supplemental Content

Support Center